S&P 500 7,680.39 â–ŧ 31.37 (-0.41%) DOW 53,221.10 â–ŧ 338.89 (-0.63%) NASDAQ 26,306.73 â–ŧ 95.70 (-0.36%) US Markets Closed â€ĸ 11:26 PM ET

OPTH

Optimi Health Corp.

Price Chart

No historical data available

Latest Quote

$4.89

-0.04 (-0.71%)
Current Price
Previous Close $4.92
Open $4.88
Day High $4.89
Day Low $4.82
Volume 3,055
Fetched: 2026-08-31T16:50:45
Stock Information
Note: Financial values converted from CAD to USD
Shares Outstanding 5.73M
Total Debt $3.71M
Cash Equivalents $9.43M
Revenue $127K
Net Income $-4.98M
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $28.00M
EPS (TTM) $-1.45
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Optimi Health Corp.

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

📰 Latest News
No news articles available at the moment. Check back later for updates on OPTH.
Period:
Loading...
Income Statement (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Revenue
Reconciled Cost Of Revenue $356,727 $85,814 $-13,812 $19,335
Cost Of Revenue $356,727 $85,814 $-13,812 $19,335
Total Revenue $307,572 $281,273 $130,653 $58,237
Operating Revenue $307,572 $281,273 $130,653 $58,237
Expenses
Interest Expense $383,602 $309,764 $31,534 $20,197
Total Expenses $3,635,287 $4,328,246 $3,934,562 $5,389,890
Rent Expense Supplemental $123,534 $213,311 $173,174 $191,201
Other Income Expense $1,022,795 - $-10,791 -
Net Non Operating Interest Income Expense $-373,275 $-307,841 $66,884 $28,102
Interest Expense Non Operating $383,602 $309,764 $31,534 $20,197
Operating Expense $3,278,559 $4,242,432 $3,948,374 $5,370,554
Other Operating Expenses $378,615 $560,457 $557,414 $632,687
Selling And Marketing Expense $24,091 $155,939 $186,802 $1,525,401
General And Administrative Expense $1,939,326 $2,620,176 $2,568,016 $2,904,511
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Net Interest Income $-373,275 $-307,841 $66,884 $28,102
Interest Income $10,327 $1,923 $98,418 $48,299
Normalized Income $-3,700,990 $-4,354,814 $-3,737,025 $-5,303,551
Net Income From Continuing And Discontinued Operation $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Net Income Common Stockholders $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Net Income $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Net Income Including Noncontrolling Interests $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Net Income Continuous Operations $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Pretax Income $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Special Income Charges $1,022,795 $0 $-10,791 $0
Interest Income Non Operating $10,327 $1,923 $98,418 $48,299
Operating Income $-3,327,715 $-4,046,973 $-3,803,910 $-5,331,653
Depreciation Amortization Depletion Income Statement $685,667 $626,215 $526,370 $211,827
Depreciation And Amortization In Income Statement $685,667 $626,215 $526,370 $211,827
Gross Profit $-49,155 $195,459 $144,465 $38,901
Amortization Of Intangibles Income Statement - - $526,370 $211,827
Depreciation Income Statement - - $526,370 $211,827
Per Share
Diluted EPS $-0.87 $-1.52 $-1.30 $-1.95
Basic EPS $-0.87 $-1.52 $-1.30 $-1.95
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-2,631,721 $-3,418,834 $-3,179,121 $-5,071,527
Total Unusual Items $1,022,795 $0 $-10,791 $0
Total Unusual Items Excluding Goodwill $1,022,795 $0 $-10,791 $0
Reconciled Depreciation $685,667 $626,215 $526,370 $211,827
EBITDA (Bullshit earnings) $-1,608,926 $-3,418,834 $-3,189,911 $-5,071,527
EBIT $-2,294,592 $-4,045,050 $-3,716,282 $-5,283,354
Diluted Average Shares $2,308,398 $2,153,387 $2,091,913 $1,874,425
Basic Average Shares $2,308,398 $2,153,387 $2,091,913 $1,874,425
Diluted NI Availto Com Stockholders $-2,678,194 $-4,354,814 $-3,747,816 $-5,303,551
Other Special Charges $-1,022,795 - - -
Research And Development $250,861 $279,643 $109,772 $96,128
Selling General And Administration $1,963,417 $2,776,116 $2,754,818 $4,429,912
Other Gand A $808,378 $925,934 $939,136 $648,515
Insurance And Claims $185,694 $234,751 $252,538 $350,747
Rent And Landing Fees $123,534 $213,311 $173,174 $191,201
Salaries And Wages $821,720 $1,246,180 $1,203,167 $1,714,048
Gain On Sale Of Ppe - $0 $-10,791 $0
Amortization - - $526,370 $211,827
Fetched: 2026-08-31
Balance Sheet (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Assets
Net Tangible Assets $4,740,737 $6,908,883 $9,531,669 $11,558,518
Total Assets $10,975,934 $10,498,582 $11,898,794 $12,134,034
Total Non Current Assets $9,658,310 $9,609,270 $10,146,662 $10,382,572
Non Current Prepaid Assets $12,661 $12,661 $11,479 $7,695
Non Current Deferred Assets $582,926 $0 - -
Current Assets $1,317,624 $889,312 $1,752,132 $1,751,462
Prepaid Assets $198,932 $79,336 $100,047 $126,639
Inventory $223,945 $645,613 $562,247 $190,999
Receivables $68,582 $89,572 $119,580 $71,214
Accounts Receivable $68,582 $89,572 $119,580 $71,214
Cash Cash Equivalents And Short Term Investments $826,165 $74,791 $970,258 $1,362,610
Cash And Cash Equivalents $826,165 $74,791 $970,258 $1,362,610
Cash Equivalents $3,608 $68,543 $68,543 $1,077,166
Cash Financial $822,558 $6,248 $901,716 $285,444
Restricted Cash - - - -
Debt
Net Debt $3,744,181 $1,886,609 $211,380 -
Total Debt $4,703,405 $1,985,051 $1,231,771 $113,692
Long Term Debt And Capital Lease Obligation $114,267 $1,268,759 $1,205,289 $50,133
Current Debt And Capital Lease Obligation $4,589,138 $716,292 $26,482 $63,558
Current Debt $4,570,346 $692,641 - -
Other Current Borrowings $4,570,346 $692,641 - -
Long Term Debt - $1,268,759 $1,181,638 -
Liabilities
Total Liabilities Net Minority Interest $6,235,198 $3,589,699 $2,367,125 $575,516
Total Non Current Liabilities Net Minority Interest $114,267 $1,268,759 $1,205,289 $50,133
Current Liabilities $6,120,931 $2,320,940 $1,161,836 $525,382
Current Deferred Liabilities $149,898 $83,976 $81,169 $0
Payables And Accrued Expenses $1,381,895 $1,520,672 $1,054,185 $461,824
Payables $1,233,773 $1,395,847 $938,486 -
Accounts Payable $855,472 $540,675 $650,687 -
Equity
Common Stock Equity $4,740,737 $6,908,883 $9,531,669 $11,558,518
Total Equity Gross Minority Interest $4,740,737 $6,908,883 $9,531,669 $11,558,518
Stockholders Equity $4,740,737 $6,908,883 $9,531,669 $11,558,518
Gains Losses Not Affecting Retained Earnings $1,529,869 $1,463,277 $1,556,822 $2,043,895
Retained Earnings $-19,654,891 $-17,035,231 $-12,730,893 $-9,687,646
Other
Ordinary Shares Number $77,471 $2,276,656 $2,093,276 $1,946,678
Share Issued $77,471 $2,276,656 $2,093,276 $1,946,678
Tangible Book Value $4,740,737 $6,908,883 $9,531,669 $11,558,518
Invested Capital $9,311,083 $8,870,283 $10,713,306 $11,558,518
Working Capital $-4,803,306 $-1,431,628 $590,296 $1,226,079
Capital Lease Obligations $133,058 $23,652 $50,133 $113,692
Total Capitalization $4,740,737 $8,177,642 $10,713,306 $11,558,518
Capital Stock $22,865,759 $22,480,837 $20,705,739 $19,202,269
Common Stock $22,865,759 $22,480,837 $20,705,739 $19,202,269
Long Term Capital Lease Obligation $114,267 $0 $23,652 $50,133
Current Deferred Revenue $149,898 $83,976 $81,169 $0
Current Capital Lease Obligation $18,791 $23,652 $26,482 $63,558
Current Accrued Expenses $148,121 $124,825 $115,699 -
Dueto Related Parties Current $378,302 $855,172 $287,799 -
Net PPE $9,062,723 $9,596,609 $10,135,183 $10,374,877
Accumulated Depreciation $-1,991,294 $-1,328,366 $-708,890 $-141,381
Gross PPE $11,054,017 $10,924,975 $10,844,073 $10,516,258
Other Properties $1,276,968 $1,262,448 $1,160,867 $822,283
Machinery Furniture Equipment $9,777,049 $9,662,527 $9,683,205 $9,656,724
Finished Goods $223,945 $619,616 $518,731 $141,682
Raw Materials $0 $25,997 $43,516 $49,317
Buildings And Improvements - $0 $0 $37,251
Properties - $0 $0 $0
Other Short Term Investments - - - $0
Construction In Progress - - - -
Land And Improvements - - - -
Fetched: 2026-08-31
Cash Flow Statement (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Free Cash Flow
Free Cash Flow $-1,959,795 $-3,199,191 $-3,178,765 $-8,463,800
Operating Activities
Operating Cash Flow $-1,896,032 $-3,089,244 $-2,598,511 $-3,304,142
Cash Flow From Continuing Operating Activities $-1,896,032 $-3,089,244 $-2,598,511 $-3,304,142
Operating Gains Losses $-1,022,810 - $10,791 -
Investing Activities
Capital Expenditure $-63,763 $-109,947 $-580,253 $-5,159,658
Investing Cash Flow $-63,763 $-111,128 $-509,391 $-2,273,655
Cash Flow From Continuing Investing Activities $-63,763 $-111,128 $-509,391 $-2,273,655
Capital Expenditure Reported $-63,763 $-109,947 $-580,253 $-5,159,658
Net Other Investing Changes - $-1,182 $60,040 -
Financing Activities
Issuance Of Capital Stock $284,993 $1,469,408 $1,330,355 $0
Financing Cash Flow $2,711,169 $2,304,905 $2,715,550 $856,105
Cash Flow From Continuing Financing Activities $2,711,169 $2,304,905 $2,715,550 $856,105
Net Other Financing Charges $-28,963 - - -
Net Common Stock Issuance $284,993 $1,469,408 $1,330,355 $0
Common Stock Issuance $284,993 $1,469,408 $1,330,355 $0
Other
Repayment Of Debt $-34,038 $-30,303 $-57,806 $-80,258
Issuance Of Debt $2,489,177 $721,501 $1,443,001 $0
Interest Paid Supplemental Data $141,455 $94,697 $0 -
End Cash Position $826,165 $74,791 $970,258 $1,362,610
Beginning Cash Position $74,791 $970,258 $1,362,610 $6,084,302
Changes In Cash $751,374 $-895,468 $-392,352 $-4,721,692
Proceeds From Stock Option Exercised $0 $144,300 $0 $936,364
Net Issuance Payments Of Debt $2,455,140 $691,198 $1,385,195 $-80,258
Net Short Term Debt Issuance $2,489,177 $0 - -
Short Term Debt Issuance $2,489,177 $0 - -
Net Long Term Debt Issuance $-34,038 $691,198 $1,385,195 $-80,258
Long Term Debt Payments $-34,038 $-30,303 $-57,806 $-80,258
Long Term Debt Issuance $0 $721,501 $1,443,001 $0
Change In Working Capital $899,497 $545,124 $596,378 $1,047,604
Change In Other Working Capital $65,922 $2,807 $81,169 -
Change In Payables And Accrued Expense $450,382 $474,353 $690,768 $87,710
Change In Payable $450,382 $474,353 $690,768 $87,710
Change In Account Payable $-33,103 $-93,019 $463,612 $87,710
Change In Prepaid Assets $935 $20,711 $26,592 $1,086,332
Change In Inventory $361,268 $17,245 $-153,785 $-190,999
Change In Receivables $20,991 $30,008 $-48,367 $64,561
Changes In Account Receivables $20,991 $30,008 $-48,367 $64,561
Other Non Cash Items $186,343 $50,937 $-102,127 $14,861
Stock Based Compensation $33,494 $43,347 $117,939 $725,190
Depreciation Amortization Depletion $685,677 $626,224 $526,378 $211,830
Depreciation And Amortization $685,677 $626,224 $526,378 $211,830
Net Income From Continuing Operations $-2,678,233 $-4,354,876 $-3,747,870 $-5,303,628
Net PPE Purchase And Sale - $0 $10,823 $0
Sale Of PPE - $0 $10,823 $0
Gain Loss On Sale Of PPE - $0 $10,791 $0
Net Investment Purchase And Sale - - $0 $2,886,003
Sale Of Investment - - $0 $2,886,003
Amortization Cash Flow - - $526,378 $211,830
Amortization Of Intangibles - - $526,378 $211,830
Purchase Of PPE - - - $-647,816
Purchase Of Investment - - - -
Depreciation - - - -
Fetched: 2026-08-31